Journal profile · Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
Pharmaceutical Sciences Asia
ISSN 2586-8195 · eISSN 2586-8470 · Mahidol University - Faculty of Pharmacy · Thailand
Pharmaceutical Sciences Asia: diamond open access (no APC); no APC; review about 5 weeks (community reports); 36 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Pharmaceutical Sciences Asia is published by Mahidol University - Faculty of Pharmacy. By OpenAlex counts of its recent articles, its largest topics are Medicinal Plant Research, Advanced Drug Delivery Systems and Pharmacy and Medical Practices, together about 25.6% of its articles. Its main subfields are Pharmaceutical Science. (generated from OpenAlex topic counts and CAS ranking data)
The Pharmaceutical Sciences Asia (PSA) journal is a double-blinded peer-reviewed journal in English published quarterly, by the Faculty of Pharmacy, Mahidol University, Thailand. The PSA journal is formerly known as Mahidol University Journal of Pharmaceutical Sciences and committed to the timely publication of innovative articles and reviews. This journal is currently available in electronic format on the website.Specific topics covered by the journal include pharmaceutical sciences and related disciplines: Biopharmaceutical Sciences Pharmaceutical Sciences and Technology Pharmaceutical Chemistry and Phytochemistry Clinical Pharmacy and Social Administrative Pharmacy
From the journal's Aims & Scope
Research area (LetPub): Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
Editor-in-chief Mullika T. ChomnawangPublisher website
Editorial board by country: none in mainland China; most named Thailand 28, United States 3, Taiwan, China 2, Japan 2, Netherlands 2 (41 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Medicinal Plant ResearchAgricultural and Biological Sciences11%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics7.7%
- Pharmacy and Medical PracticesPharmacology, Toxicology and Pharmaceutics6.9%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics6.7%
- Analytical Methods in PharmaceuticalsChemistry6.7%
- Antibiotic Use and ResistanceImmunology and Microbiology5.4%
- Pharmaceutical Practices and Patient OutcomesMedicine5%
- Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| General Pharmacology, Toxicology and Pharmaceutics | Q3 | 59/79 | 25th |
| Pharmacology (medical) | Q4 | 216/278 | 22nd |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 1.1LetPub ·
- SJR 2026-06
- 0.19LetPub ·
- SNIP 2026-06
- 0.29LetPub ·
- h-index
- 12OpenAlex ·
- i10-index
- 21OpenAlex ·
- 2-year mean citedness
- 0.64OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 406 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 36 | 36 | 194 |
| 2025 | 36 | 36 | 240 |
| 2024 | 52 | 52 | 194 |
| 2023 | 40 | 40 | 198 |
| 2022 | 65 | 65 | 151 |
| 2021 | 61 | 61 | 81 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 5 weeksLetPub ·
- Submission to publication (journal-reported)
- about 5 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY-NC-ND | |
| Publisher website | No APC | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- ≥ 3
- Manuscript length
- ≤ 6,000 words
- Reference style
- Vancouver
- First submission
- Free format: the journal's layout is not required
- Cover letter
- Required
Article types accepted9, with length limits
- letters to the editorReaders are invited to give an opinion on a scientific or technical subject within the scope of the Journal.Length not stated
- original articlesArticles are comprehensive accounts of significant experimental of theoretical results.Length not stated
- research articleResearch ArticleLength not stated
- research articlesThe journal publishes research articles, review articles, and scientific commentaries on all aspects of the pharmaceutical sciences and related fields in health…Length not stated
- review articleReview ArticleLength not stated
- review articlesReview articles provide a summary of topics of general interest to pharmacists and are limited to 6,000 words.Length not stated
- scientific commentariesThe journal publishes research articles, review articles, and scientific commentaries on all aspects of the pharmaceutical sciences and related fields in health…Length not stated
- short communicationists and are limited to 6,000 words. 3. Short Communications Communications are preliminary reports limited to approximately 2,000 words including 1-2 table(s)/…main text ≤ 2,000 words
- short communicationsCommunications are preliminary reports limited to approximately 2,000 words including 1-2 table(s)/ figure(s) with not more than 15 references.Length not stated
Policy excerpts from the journal's websiteAuthorship, Publication ethics, License & copyright, Open access, Peer review
- Authorship
Authors must sign a Consent to publish and Copyright transfer form upon submission. Model summary
Upon the submission, all author(s) shall sign for and accepts responsibility for releasing the article in the Consent to publish and Copyright transfer form.
Source ↗Publisher website ·- Publication ethics
Authors must have authority for publication and comply with animal experiment, clinical study, and biodiversity rules. Model summary
Manuscripts are accepted with the understanding that authors have obtained the authority for publication, and they have performed the studies under the rules for animal experiments, clinical studies, and biodiversity rights.
Source ↗Publisher website ·- License & copyright
Licensed under CC BY-NC-ND 4.0. Model summary
Pharmaceutical Sciences Asia by Faculty of Pharmacy, Mahidol University, Thailand is licensed under CC BY-NC-ND 4.0
Source ↗Publisher website ·- Open access
Open access: all articles freely available via journal website. Model summary
All articles published in our journal are open access and are freely and widely available to all readers via the journal website.
Source ↗Publisher website ·- Peer review
Originality: manuscripts must not have been previously published or be under consideration elsewhere. Model summary
Manuscripts submitted for publication in this journal must not have been previously published and are not under consideration for publication in any other media.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Mahidol University - Faculty of Pharmacy
- Country or region
- Thailand
- Language
- English
- ISSN
- 2586-8195
- Electronic ISSN
- 2586-8470
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Pharmaceutical Sciences Asia
How long does peer review take at Pharmaceutical Sciences Asia?
Authors report an average review time of about 5 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Pharmaceutical Sciences Asia?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≥ 3; Manuscript length: ≤ 6,000 words; Reference style: Vancouver; First submission: Free format: the journal's layout is not required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Pharmaceutical Sciences Asia based?
Of the 41 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Thailand (28), United States (3) and Taiwan, China (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Pharmaceutical Sciences Asia?
According to LetPub and DOAJ records, Pharmaceutical Sciences Asia is indexed in Scopus and DOAJ.
Is Pharmaceutical Sciences Asia open access, and what is the APC?
Pharmaceutical Sciences Asia is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .